Literature DB >> 8527265

Effect of captopril, enalaprilat and mercaptopropionyl glycine (MPG) on the oxidative activity of human isolated neutrophils.

M Clapperton1, P H Beswick, I Abdullah, H J Dargie, A C Fisher, J McMurray.   

Abstract

1. Neutrophil NADPH oxidase produces the superoxide anion (O2-) anion radical from oxygen. The thiol containing ACE inhibitor, captopril has been reported to inhibit isolated NADPH oxidase. The above effect of captopril, if present in intact cells, could contribute to the ability of this drug to alleviate neutrophil-mediated tissue damage. We have, therefore, investigated the effect of captopril on the oxidative activity of intact human isolated neutrophils. 2. The effects of captopril on neutrophil oxidative activity were compared with those of enalaprilat (a non-thiol ACE inhibitor) and N-mercaptopropionyl glycine (MPG) (a simple thiol). 3. The oxidative response of PMA-stimulated neutrophils measured by lucigenin chemiluminescence was not affected by any of these test agents. The thiol captopril and MPG (but not enalaprilat) caused an initial delay in luminol chemiluminescence production by PMA-stimulated neutrophils. 4. Captopril and MPG (but not enalaprilat) increased, rather than decreased oxygen uptake, when added to PMA-stimulated neutrophils. Thiol oxidation was determined to be, at least partly, responsible for the excess oxygen uptake observed. 5. NADPH oxidase activity in intact neutrophils was not affected by captopril, MPG or enalaprilat. The inhibition of NADPH oxidase activity is unlikely to contribute to the therapeutic effects of captopril and other thiols.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527265      PMCID: PMC1365024          DOI: 10.1111/j.1365-2125.1995.tb04531.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Superoxide-dependent oxidation of extracellular reducing agents by isolated neutrophils.

Authors:  E L Thomas; D B Learn; M M Jefferson; W Weatherred
Journal:  J Biol Chem       Date:  1988-02-15       Impact factor: 5.157

2.  Angiotensin converting inhibitors in rheumatoid arthritis.

Authors:  I Jaffe
Journal:  Arthritis Rheum       Date:  1984-07

3.  Photophysical properties of rose bengal and its derivatives (XII).

Authors:  J Paczkowski; J J Lamberts; B Paczkowska; D C Neckers
Journal:  J Free Radic Biol Med       Date:  1985

4.  Superoxide, hydrogen peroxide and singlet oxygen in hematoporphyrin derivative-cysteine, -NADH and -light systems.

Authors:  G R Buettner; R D Hall
Journal:  Biochim Biophys Acta       Date:  1987-03-19

5.  Luminol- and lucigenin-dependent chemiluminescence of neutrophils: role of degranulation.

Authors:  S W Edwards
Journal:  J Clin Lab Immunol       Date:  1987-01

Review 6.  The role of the neutrophil in rheumatoid arthritis.

Authors:  E Kitsis; G Weissmann
Journal:  Clin Orthop Relat Res       Date:  1991-04       Impact factor: 4.176

7.  Role of myeloperoxidase in the respiratory burst of human neutrophils.

Authors:  W M Nauseef; J A Metcalf; R K Root
Journal:  Blood       Date:  1983-03       Impact factor: 22.113

8.  Captopril: a new treatment for rheumatoid arthritis?

Authors:  M F Martin; K E Surrall; F McKenna; J S Dixon; H A Bird; V Wright
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

9.  Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors.

Authors:  M Chopra; H Beswick; M Clapperton; H J Dargie; W E Smith; J McMurray
Journal:  J Cardiovasc Pharmacol       Date:  1992-03       Impact factor: 3.105

Review 10.  Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion.

Authors:  K M Mullane; W Westlin; R Kraemer
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.